Dr. Stephanie Venn-Watson

Maybe us docs inside should have been involved in branding a disease name.

Maybe us docs inside should have been involved in branding a disease name.

So there you go. So I'll call it fatty liver disease, not associated with alcohol. So that wasn't known until Mayo Clinic published a paper in 1980 for the first 20 cases. And then, so since then, we move fast forward to today, the latest paper showed 38% of people globally have fatty liver disease.

So there you go. So I'll call it fatty liver disease, not associated with alcohol. So that wasn't known until Mayo Clinic published a paper in 1980 for the first 20 cases. And then, so since then, we move fast forward to today, the latest paper showed 38% of people globally have fatty liver disease.

So there you go. So I'll call it fatty liver disease, not associated with alcohol. So that wasn't known until Mayo Clinic published a paper in 1980 for the first 20 cases. And then, so since then, we move fast forward to today, the latest paper showed 38% of people globally have fatty liver disease.

So this has been a alarming rise in people with fatty liver disease, a percentage of which are progressed to steatohepatitis, inflammation, cirrhosis, becoming one of the leading causes of liver transplants and liver cancer.

So this has been a alarming rise in people with fatty liver disease, a percentage of which are progressed to steatohepatitis, inflammation, cirrhosis, becoming one of the leading causes of liver transplants and liver cancer.

So this has been a alarming rise in people with fatty liver disease, a percentage of which are progressed to steatohepatitis, inflammation, cirrhosis, becoming one of the leading causes of liver transplants and liver cancer.

That's right. None of the, we don't want any of those things.

That's right. None of the, we don't want any of those things.

That's right. None of the, we don't want any of those things.

That's right.

That's right.

That's right.

Exactly. And so when Jeff Schwimmer is a leader in pediatric fatty liver disease, and he opened the first clinic for fatty liver disease for kids. And so Jeff, back in 2012, had published a paper on fatty liver disease in dolphins. And he wrote me, he sent me an email and he's like, ah, it's probably not what we're seeing in people.

Exactly. And so when Jeff Schwimmer is a leader in pediatric fatty liver disease, and he opened the first clinic for fatty liver disease for kids. And so Jeff, back in 2012, had published a paper on fatty liver disease in dolphins. And he wrote me, he sent me an email and he's like, ah, it's probably not what we're seeing in people.

Exactly. And so when Jeff Schwimmer is a leader in pediatric fatty liver disease, and he opened the first clinic for fatty liver disease for kids. And so Jeff, back in 2012, had published a paper on fatty liver disease in dolphins. And he wrote me, he sent me an email and he's like, ah, it's probably not what we're seeing in people.

Like it's probably not the same disease, but send me some liver slides that you have, you know, and let me get back to you.

Like it's probably not the same disease, but send me some liver slides that you have, you know, and let me get back to you.

Like it's probably not the same disease, but send me some liver slides that you have, you know, and let me get back to you.